At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MEDP Medpace
Post-Market Trading 12-31 19:49:28 EST
332.23
-1.11
-0.33%
盘后335.99
+3.76+1.13%
19:32 EST
High337.45
Low332.17
Vol149.78K
Open334.96
D1 Closing333.34
Amplitude1.58%
Mkt Cap10.30B
Tradable Cap8.46B
Total Shares31.01M
T/O49.97M
T/O Rate0.59%
Tradable Shares25.45M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Truist Financial Issues a Hold Rating on Medpace Holdings (MEDP)
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.